Author Topic: Alemtuzumab under scrutiny because of risk of stroke in some patients with MS  (Read 24 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest

The Lancet (April 27, 2019) contains an article on this topic though there is no easy access to it. However, another article (from Lancet Neurology, February 15) (see link below) explains the situation under discussion:


Quote
Reports of stroke in patients having taken alemtuzumab for multiple sclerosis prompt a safety review by the European Medicines Agency.


The February 15 article, "Intracerebral hemorrhage during alemtuzumab administration":

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30076-6/fulltext
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest


Presented at the annual AAN conference, "Spontaneous Intracerebral Hemorrhage During Administration of Alemtuzumab for Multiple Sclerosis: A Case Series":


http://indexsmart.mirasmart.com/AAN2019/PDFfiles/AAN2019-001167.pdf




MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics